SEC Filing Summary: Cerecor Inc. (CERC)
Business Context and Reporting Period
This Form 8-K was filed by Cerecor Inc. on October 13, 2020, reporting events occurring on October 8, 2020. The registrant is a Delaware corporation listed on the Nasdaq Capital Market under the symbol CERC. The filing identifies the company as an Emerging Growth Company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the appointment of Gilla Kaplan, Ph.D., to the Board of Directors, effective October 8, 2020. Dr. Kaplan will serve until the 2021 Annual Meeting of Stockholders or until a successor is elected. She has been appointed to chair the newly formed Science and Technology Committee, which also includes Drs. Barer, Bruhn, and Persson.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. No specific risks or contingencies are detailed in this report. The Board confirmed that Dr. Kaplan satisfies the independence requirements of Nasdaq Rule 5605(a)(2) and SEC Rule 10A-3. There are no related party transactions or family relationships between Dr. Kaplan and other directors or officers.
Key Facts for Investor Verification
- Dr. Kaplan's appointment to the Board and her role as Chair of the new Science and Technology Committee.
- Confirmation that Dr. Kaplan is eligible for compensation under the Non-Employee Director Compensation Plan.
- Verification of the company's status as an Emerging Growth Company.
- Review of the attached Press Release (Exhibit 99.1) dated October 12, 2020, for additional context.